© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Prasugrel didn’t just pop into the world of cardiology one day—the climb took decades. Researchers wanted to create a drug that would do a better job of stopping platelets without the scare of unexpected side effects. The late 1990s turned into a pressure cooker as scientists kept running into bleeding problems when trying alternatives to clopidogrel. Sankyo and Eli Lilly dug in, looking to tweak the structure of thienopyridine compounds. By around 2009, prasugrel won approval from the FDA, promising clearer benefits for people with acute coronary syndrome headed for PCI. Prasugrel’s launch marked another round in the battle to keep stents open and reduce stent-related clots. It took several large-scale clinical trials—TRITON-TIMI 38 stands out—to nudge the drug into hospitals and the lives of countless heart patients facing tough odds.
Doctors often reach for prasugrel where there’s a need for strong platelet inhibition—typically after placing a stent in the heart. Prasugrel comes in tablet form, usually yellow or beige, easy to swallow, and clearly marked for proper dosing. Each dose offers consistent delivery of active medicine, making it easier for providers to educate patients about expectations and what side effects might show up. Health systems worldwide stock prasugrel in blister packs, keeping it protected from moisture and heat, reducing the chance of accidental contamination. Unlike its cousin clopidogrel, prasugrel shows faster, more predictable action, which helps doctors provide more reliable care on busy heart units and in fast-moving emergencies. Drug formularies outline specific rules for use, but it often finds a home in advanced, riskier cases.
Prasugrel shows up as a fine, white-brown powder, nearly odorless, with a melting point close to 147°C. It barely dissolves in water, favoring organic solvents like ethanol or acetonitrile. As a prodrug, prasugrel waits for metabolic activation in the body before releasing its punch. Its chemical makeup—C20H20FNO3S—includes both hydrophobic and hydrophilic elements, giving the molecule unique absorption behavior after swallowing. It lands in the blood as a stable compound, with a proven shelf life of two to three years if stored properly. The powder resists breakdown in light but needs dry, cool storage to prevent clumping or degradation, especially in humid areas. Routine checks ensure that every batch shipped to hospitals meets established purity benchmarks, so patients and doctors know exactly what they’re getting.
Packaging always spells out the active ingredient, strength (most often 5 mg or 10 mg per tablet), manufacturer’s name, expiration date, storage recommendations, and batch numbers. Labels must also display the regulatory approval ID, helping track medicines in case of a recall or query. Instructions warn against use in people with active bleeding, recent stroke, or severe liver problems. Sensitive populations—notably older adults and those under 60 kg—get special dosing instructions reflecting results seen in clinical studies. Health professionals check for interactions before prescribing prasugrel with other antiplatelet agents or blood thinners to avoid excessive risk. Pharmacies keep detailed inserts explaining side effects in plain language, giving patients a way to look up details without digging through journals.
Chemists synthesize prasugrel through a multi-step process, starting with a thienopyridine core. The reaction mix absorbs a trifluoromethyl group, then cyclizes with the proper chiral control to give the required stereochemistry. Alkylation steps attach the cyclopropyl and acetic acid groups, creating the balance between lipid and water solubility. Reagents, catalysts, and precise timing protect yields and keep impurities out. Strict quality controls check every batch for unwanted byproducts like residual solvents, which could impact safety. Synthetic protocols undergo minor tweaks over time as commercial manufacturers chase better cost efficiency and greener methods, but the essential backbone of the chemistry remains unchanged. Final crystallization and purification steps prepare the material for tablet production, where uniform granulation ensures equal drug content in every unit.
Prasugrel stands as a classic prodrug; it doesn’t block platelet receptors straight away. After swallowing, the liver’s cytochrome P450 enzymes turn prasugrel into its active metabolite—a thiol group that binds irreversibly to the P2Y12 receptor on platelets. This reaction forms a disulfide bridge, “locking” the receptor and blunting platelet activation for days. Researchers have explored small tweaks to this core structure—changing the ester group or fiddling with ring substituents—but few modifications reached the same combination of strong action and low variability as prasugrel. Every modification needs to balance potency with safety. Studies in medicinal chemistry journals often describe failed analogs that caused too much bleeding or lost anti-clotting action. Prasugrel’s balance helped it stand out in a crowded therapeutic field.
The drug’s international nonproprietary name is prasugrel, but it appears in pharmacies worldwide under a few different brand labels. Effient and Efient are the best known, found on prescription pads in North America, the UK, and beyond. Some countries allow local generics using the same name once patents expire. Chemical catalogues and research papers also mention “CS-747,” which works as prasugrel’s original research code. In databases and clinical trial registries, you’ll spot synonyms like “Prasugrel Hydrochloride” or “Prasugrelum,” though patients seldom hear these terms in conversation with their doctors.
Doctors don’t hand out prasugrel without a careful look at the patient’s history. Anyone with active internal bleeding, history of brain hemorrhage, or major surgery coming up gets a hard stop. Prescribers always weigh bleeding risk—especially in people over 75 or anyone weighing less than 60 kilograms. The product’s label and regulatory monographs urge screening for drug interactions, laying out precautions for use with NSAIDs, anticoagulants, or other agents that thin the blood. Medical staff train on signs of internal bleeding, so side effects can get caught early. Pharmacies and wholesalers keep the tablets protected from humidity or bright light to avoid chemical change, and maintain stock rotation so no batch sits on the shelf beyond its prime. Proper handling in the clinic means single dispensing and double-checking patient identifiers to dodge medication errors.
Cardiologists prescribe prasugrel mainly after angioplasty with stent placement, aiming to prevent future heart attacks by blocking the P2Y12 receptor on platelets. Its strong, fast action makes it a go-to in urgent coronary events when time matters and variability spells danger. Stroke prevention sometimes enters the conversation, but bleeding risk narrows its use compared to other antiplatelet drugs. Hospitals keep it ready for ambulance crews and intensive care teams under specific protocols, limiting it to patients most likely to benefit. Outpatient use focuses on those continuing dual antiplatelet therapy months after a stent, helping to keep new blockages from forming. Dental and surgical teams always ask about prasugrel use before planning any procedure, protecting patients from unexpected bleeding complications during minor or major operations.
Prasugrel’s story pushes on in research labs and clinical journals. Scientists look for ways to stretch its use to more patients while cutting down bleeding risk. Genetic tests—targeting CYP2C19 metabolic variants—help doctors decide if another agent might work better for some people. Pediatric trials hover at the edge, raising questions about how young bodies handle platelet blockers. Pharmaceutical teams keep designing new formulations—like dispersible tablets or narrow-dose options—to fine-tune therapy for special populations and simplify administration in crowded wards. Researchers run head-to-head comparisons with next-generation agents like ticagrelor, examining which patients tolerate which drugs better and how each one fits in when cost, safety, and lifestyle enter the picture. Publications in top medical journals drive updates in prescribing guidelines, keeping the pressure on to improve both care and outcomes.
The strongest concern with prasugrel stems from bleeding, and research groups track these risks over thousands of cases. Clinical trials showed patients taking prasugrel experienced more severe bleeding—particularly gastrointestinal or brain hemorrhage—than some alternative agents, especially in older people or those with low body weight. Animal studies from the early days reported no increase in tumor development or organ toxicity, supporting the safety case for eventual approval. Chronic toxicity research includes careful long-term monitoring of liver and kidney function, though few serious signals have materialized outside of occasional allergic reactions. Researchers check whether new metabolic byproducts stack up with other medications in the body, looking for rare reaction clusters or genetic outliers. Regulators worldwide audit these studies, enforcing transparent reporting of every serious side effect so the risk-benefit picture remains in focus.
Prasugrel’s path forward looks shaped by emerging technologies and a deeper dive into precision medicine. Pharmacogenomics stands ready to match antiplatelet drugs to patient DNA, offering doctors new tools to avoid bleeding in sensitive groups while making sure nobody misses out on life-saving treatment. Drug companies work on easier dosing schedules, pushing toward once-daily or even long-acting versions that could take some of the hassle out of daily pill routines. As artificial intelligence and big data organize treatment records, patterns may surface that allow for smarter, safer prescribing practices. The drive for value-based care puts drug pricing in the spotlight, challenging manufacturers to balance innovation with access for health systems everywhere. Doctors and patients both press for therapies that make strong prevention easier, safer, and better tailored to people’s lives, rather than forcing a one-size-fits-all approach. As research grows, the world expects antiplatelet therapies to get even sharper, more personal, and more effective at keeping people healthy after a heart scare.
People living with heart disease often hear about all sorts of complicated treatment options, but among these, Prasugrel is a name that comes up, especially in conversation with cardiologists after a heart attack or for those who’ve had certain stents placed in their arteries. Prasugrel belongs to a class of medicine called antiplatelet drugs, which means it helps lower the chance blood clots will form inside blood vessels.
Blood clots sit high on the list of things that can go wrong after a heart problem. Usually, doctors prescribe Prasugrel along with aspirin for patients who have had a major heart event, like a heart attack, or for those who have undergone a procedure where a stent is inserted to keep a blood vessel open. Keeping these vessels clear is crucial because blocked arteries stop blood from reaching parts of the heart, and this can set off another heart attack or strokes. The science backing this drug is strong. Research, including the notable TRITON-TIMI 38 study, found that Prasugrel reduced the risk of future heart attacks compared to some older drugs, but it increased the chance of serious bleeding.
Prasugrel makes platelets less likely to stick together and form clots. To someone who’s already been through a heart event, this makes a huge difference—especially considering clots are like roadblocks for blood flow. One practical lesson many people learn is that missing even a single dose can lead to problems. The medicine wears off quickly, so clots can form again if pills aren’t taken as prescribed.
Still, every benefit has its cost. Some people develop severe bruising or bleeding; a small cut might bleed for a lot longer, and dental work can turn tricky. I’ve seen patients hesitating to take Prasugrel after reading about these risks. Doctors now pay close attention to a patient’s age, body weight, and history of bleeding before starting them on this medicine. The FDA recommends against using Prasugrel in anyone who has had a stroke or mini-stroke due to the higher danger of bleeding.
People sometimes ask if there are ways to avoid these risks. The answer comes down to honest conversations with doctors, regular check-ups, and not starting Prasugrel before doctors rule out high-risk factors. Also, some folks don’t realize over-the-counter pain relievers and herbal supplements can interact badly with Prasugrel. Letting the care team know about every medication in your routine really helps.
Consistency is a big part of success with Prasugrel. Skipping doses or stopping on your own can be dangerous. Pharmacists recommend using pillboxes or reminders to stay on track, especially after leaving the hospital when routines change.
Newer antiplatelet medicines are being researched for better safety and convenience, though nothing replaces personalized advice. Prasugrel remains a tool that saves lives for the right people. Managing heart disease rests on real partnerships between people and their doctors, honest discussion of risks, and attention to other health conditions. Knowledge and simple, clear communication have proven to make all the difference here.
Doctors prescribe Prasugrel to help prevent blood clots after a stent or heart attack. A busy clinic often sees people relieved this drug is available, but a lot of folks walk in worried about what could happen after they start taking it. Let’s talk about those effects you’re most likely to notice—not just the ones tucked away in the pharmacy leaflet, but the ones that actually disrupt sleep or add to daily stress.
Prasugrel works by thinning out your blood, so bleeding problems top the list. This can show up as nosebleeds that last longer than usual, gums bleeding after you brush, or bruises that stick around way too long. People often get concerned the first time they nick themselves shaving or bump into a table and see a bruise by the day’s end.
Serious bleeding scares most patients the most. Some notice pink urine or black stools—clear warning signs to call the doctor. Hospitals do keep track of these risks, and most doctors will walk you through warning signs, because numbers show that serious bleeding, though uncommon, can happen in real life, not just in papers.
It’s not only the serious stuff. I’ve met a lot of folks who get stomach pain, nausea, or even diarrhea during the first weeks. Most just feel it’s a bad stomach day, but sometimes it sticks around. For some, eating with the medicine helps. Others find switching mealtimes around does the trick.
Headaches show up for some patients. This one rarely lasts, but it can make those first days tougher. Joint pain or muscle aches may show up as well. Nobody likes swapping one pain for another, and doctors try to find the right mix of drugs to bring comfort without too many tradeoffs.
Allergic reactions remain rare, but hives, rash, or itching have sent patients back to their doctors. Any sign like this usually leads to a switch in medication. It doesn’t happen to everyone, but I’ve seen people simply feel wrong in their skin and ask for something different.
Doctors watch people on Prasugrel closely. They don’t just write a prescription and walk away. They look at your medical history, age, and other prescriptions. Elderly patients or those with a previous stroke carry higher risks. The FDA actually recommends caution in these groups, and hospitals stay alert for complications.
Talking with your healthcare team builds trust and understanding. People who track how they feel after starting Prasugrel often have the best shot at quick solutions if something feels off. A nurse once told me that small changes—using a soft toothbrush, skipping contact sports—make real differences in day-to-day life for patients worried about bruising or bleeding.
Honest conversations matter. Simple tips—report bleeding that won’t quit or sudden pain, never skip doses or stop medicine on your own. Check in about any supplements or over-the-counter stuff, because mixing them with Prasugrel spells trouble sometimes. With the right care, most patients take Prasugrel safely. If side effects sneak up, talking it over early beats staying silent.
Prasugrel steps in as a key player for people who have heart problems, especially for those who’ve had a stent placed after a heart attack. Doctors prescribe this medication to help prevent future blood clots, which could save lives in the long run. Heart disease affects so many families, including my own. That’s part of why I pay close attention to how folks take medications like prasugrel, since missing details can lead to bad outcomes.
Most people get prasugrel as a tablet, once every day, usually at the same time. Swallow the pill whole, and skip crushing or breaking it. The timing sticks, even if it feels repetitive—consistency helps your body build up protection against clots. Food isn’t required with prasugrel, so you can take it with meals or on a clear stomach. Some people say it upsets their stomach a little if taken alone, so they might find relief by pairing it with breakfast or dinner. Missing a dose means you might not have enough medicine in your blood to block clots, so try to build it into your routine. Something as simple as leaving the bottle by your toothbrush reminds you every morning.
This medication can lower your risk for heart attacks or strokes, but it also bumps up your chance of bleeding. If you see more bruises or notice your gums bleed longer after brushing, that could be a side effect. Heavy bleeding—nosebleeds that won’t stop, coughing up blood, black stools—calls for a doctor’s attention right away. I’ve met people who stopped taking their pills because of these side effects, but that’s risky. Before making any changes, talking with a pharmacist or doctor opens the door to adjustments or extra safety steps. Some patients need extra attention if they have a history of stroke or bleed easily, so make sure your care team knows your history.
Lots of folks juggle several prescription drugs and supplements—mixing some with prasugrel can create problems. Medicines like warfarin or ibuprofen team up to increase bleeding risk. Vitamin E and some herbal products can do the same. Keeping an updated list of everything you take—prescriptions, over-the-counter pills, vitamins—makes doctor visits smoother and safer. I helped my uncle organize his meds, and his cardiologist spotted an issue he would’ve missed. That extra ten minutes saved him a hospital visit later.
People sometimes worry about side effects or cost, and stop taking the drug on their own. That’s risky, as sudden withdrawal can boost the odds of a blood clot forming. Insurance, pharmacy programs, or talking with the doctor can clear up those worries. Every year, patients end up in the hospital from stopping heart medications without checking in first. If you ever feel unsure, let your medical team guide you—solutions exist, and skipping the drug alone can backfire.
Regular check-ins help manage side effects and catch problems early. Blood work, blood pressure checks, and honest updates about symptoms can tell your doctor a lot. It’s not always easy, and sometimes it feels repetitive, but those conversations catch problems early. If you feel lost at any point, bring a family member to appointments or write questions in advance.
No one can avoid all risks, but staying informed gives you a better shot at a healthy future. Clear instruction, family support, and open communication with your healthcare team make all the difference. In my experience, the more involved patients get, the better the outcomes.
Prasugrel became popular after studies showed it cut down the risk of heart attacks or strokes, especially for folks who got stents after a heart attack. It works by stopping platelets from sticking together, which helps keep blood clots away. That sounds great on the surface, but some people end up in bigger trouble if they take this drug. Not every medicine fits every patient, and Prasugrel illustrates that better than most pills sitting in a cardiologist’s office drawer.
The biggest problem with Prasugrel focuses on bleeding. Some folks just can’t afford to bleed more easily. Anyone with a history of stroke—or even a fleeting mini-stroke—should steer clear. Studies like TRITON-TIMI 38 made this pretty clear: previous stroke patients given Prasugrel ran into major, sometimes deadly, bleeds. Bleeding in the brain tops the list of dangers. Taking that information home, doctors learned to keep Prasugrel away from anyone with an old stroke in their chart.
Age doesn’t only add wisdom; it shifts how drugs work inside the body. People older than 75 face more risk of bleeding on Prasugrel, especially if they take other blood thinners or have kidney problems. A lighter body also makes a difference. Anyone under 60 kg (about 132 pounds) has higher levels of this drug in their blood, even at so-called “regular” doses. For these folks, the higher risk of bleeding sometimes outweighs any upside.
Health agencies like the FDA and the European Medicines Agency called out these groups for good reason. My own patients over 75—or those who look frail, sometimes from cancer or undernutrition—would often get safer options like clopidogrel instead. I’ve seen older family members bounce back well from a heart procedure simply because their doctor chose a less risky approach.
Some allergies turn up on medication lists, but with Prasugrel, a known allergy or reaction to any of its components closes the door to its use, period. Folks with active bleeding problems—think stomach ulcers, colon polyps, nosebleeds, or recent injuries—should always stay away from it. I’ve watched friends with stomach ulcers suffer after medicines triggered another round of bleeding, which kept them in the hospital instead of heading home.
Prasugrel combines badly with certain other medicines. Blood-thinners like warfarin, DOACs, or even regular aspirin add up the risk. A surgeon planning any kind of operation—dental work included—would insist on pausing drugs like Prasugrel well ahead of time. The ingredient can linger in the blood and raise the risk of surgical bleeding, sometimes days after stopping it.
Doctors and pharmacists lean on clear communication. They ask questions about family history, surgeries, past strokes, and current medications before sending anyone home with a prescription. A single pill rarely sorts out heart problems for everyone the same way. Good care means working through the risks and picking the right tool for each person’s story. Prasugrel helps many, but skipping it for the right people can save a trip to the emergency room—or worse.
Prescription drugs are supposed to help, but things get complicated fast, especially with blood thinners like prasugrel. Doctors often hand out this pill to people with heart disease, usually after placing a stent in the arteries. Prasugrel makes blood less likely to form clots—a big win for avoiding another heart attack. Still, everyone who uses it deserves to know that some medicines and supplements in your cabinet can tangle up with prasugrel, turning a useful tool into a potential problem.
Mixing drugs doesn’t always give you a warning. I remember seeing patients who, after adding something as simple as aspirin or ibuprofen to their daily pills, would land back in the clinic with bruises and nosebleeds that took forever to stop. Taking multiple blood thinners can do that. Prasugrel teamed up with other blood thinners—think warfarin, heparin, or even over-the-counter painkillers—can raise the chances of bleeding. It’s easy to grab acetaminophen or an ibuprofen tablet for a headache without thinking, but that routine action sometimes makes the difference between a mild bruise and a medical emergency.
The list doesn’t stop at other blood thinners. Select antidepressants, like SSRIs (for example, fluoxetine or sertraline), also play with the body’s platelet chemistry and may lead to more bleeding when taken with prasugrel. People with anxiety or depression face a puzzle where their mental health and heart health medicines can work against each other. I’ve watched patients become frustrated, needing to choose which risk they’re willing to bear. It’s never a fair position to be in.
The way prasugrel gets activated in the body happens mostly in the liver. Strong medicines like ketoconazole (an antifungal) or HIV medicines can mess with liver enzymes and change the speed at which prasugrel gets processed. That might mean a weaker blood thinner in the bloodstream, lowering protection against clots but still raising the risk for side effects. On the flip side, antibiotics like erythromycin or antifungal pills such as fluconazole can make prasugrel build up, bringing bleeding risks up another notch.
Natural supplements and herbal products can surprise, too. Ginkgo, garlic, and turmeric get tossed into smoothies or teas, often without a glance at their effects. These can thin blood as well and worsen side effects, even if no prescription label says so. I once heard from a woman who felt healthier having added garlic capsules but started bleeding from her gums, only to link it back to her new supplement routine after a frank talk with her pharmacist.
Doctors and pharmacists can help sort out this mess, but they need to know the full story. Patients sometimes feel embarrassed to admit they’re taking vitamins, supplements, or occasional over-the-counter pills, and that silence can backfire. A comprehensive list—right down to occasional doses or herbal teas—makes a difference. While no single test or smartphone app can flag every possible interaction, staying open and detailed with healthcare providers sets the best foundation.
Pharmacists are uniquely positioned to catch dangerous combinations. Pharmacy records have flagged odd pairings more than once in my own experience, saving patients from side effects before they start. Some clinics use medication review sessions, and these meetings deserve a spot in regular care, not just as an afterthought. For high-risk medicines like prasugrel, layering in more education helps everyone remember the stakes are high. Regular reminders and honest conversations help patients weigh risks, make safe choices, and stick to what counts—staying healthy enough to live the lives they want.
| Names | |
| Preferred IUPAC name | 5-[(1RS,2SR,5RS)-2-cyclopropyl-1-(2-fluorophenyl)-2-hydroxy-ethyl]-4H-1,2,3,4-tetrahydrothieno[2,3-c]pyridin-7-yl acetate |
| Other names |
CS-747 Effient Efient |
| Pronunciation | /ˈpræs.juː.ɡrəl/ |
| Identifiers | |
| CAS Number | 389574-19-0 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Prasugrel** (from PubChem): ``` CCOC(=O)COC1=CC=CC=C1C2=CC=CC=C2COC(=O)OC ``` This is the SMILES string, which can be used in JSmol to generate the 3D molecular structure of Prasugrel. |
| Beilstein Reference | 1483661 |
| ChEBI | CHEBI:47175 |
| ChEMBL | CHEMBL1201197 |
| ChemSpider | 68243012 |
| DrugBank | DB06209 |
| ECHA InfoCard | 100.223.921 |
| EC Number | 3.1.3.48 |
| Gmelin Reference | Gmelin Reference: 105329 |
| KEGG | D08525 |
| MeSH | D000072633 |
| PubChem CID | 6918283 |
| RTECS number | TC83T9245T |
| UNII | 47O6U6X9LM |
| UN number | UN3481 |
| CompTox Dashboard (EPA) | DTXSID2088658 |
| Properties | |
| Chemical formula | C20H20FNO3S |
| Molar mass | 409.47 g/mol |
| Appearance | Yellowish white powder |
| Odor | Odorless |
| Density | 1.2 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | 2.1 |
| Vapor pressure | 1.7E-20 mmHg |
| Acidity (pKa) | pKa = 3.45 |
| Basicity (pKb) | 2.90 |
| Magnetic susceptibility (χ) | -23.7e-6 cm^3/mol |
| Refractive index (nD) | 1.603 |
| Dipole moment | 3.09 ± 0.2 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 377.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -359.7 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -7331 kJ/mol |
| Pharmacology | |
| ATC code | B01AC22 |
| Hazards | |
| Main hazards | Bleeding, thrombotic thrombocytopenic purpura (TTP), hypersensitivity reactions |
| GHS labelling | GHS labelling: "Warning; H302 – Harmful if swallowed. |
| Pictograms | cardiac therapy|oral use|prescription only medicine|keep out of reach of children|do not use in pregnancy |
| Signal word | Warning |
| Hazard statements | No hazard statements. |
| Precautionary statements | Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 1, Instability: 0, Special: |
| Flash point | > 407.2 °C |
| Lethal dose or concentration | The oral LD50 of prasugrel in rats is >2000 mg/kg. |
| LD50 (median dose) | LD50 (median dose) of Prasugrel: "2000 mg/kg (rat, oral) |
| NIOSH | XP3677000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | Treatment and prevention of atherothrombotic events in acute coronary syndrome (with PCI) |
| Related compounds | |
| Related compounds |
Clopidogrel Ticlopidine Ticlopidine hydrochloride Cangrelor Ticagrelor |
